The @fda.gov has approved the first therapy for glycogen storage disease type Ia (GSDIa).
Genglycos (pariglasgene brecaparvovec-opnr) received accelerated approval for patients aged 8 years and older.
Link in the comments 👇
@thebabaklab.bsky.social